Related Experiment Video

Updated: Jun 25, 2025

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

2.9K

Plain Language Summary of the PAISLEY study: deucravacitinib as a treatment for people with systemic lupus

Eric F Morand1, Marilyn Pike2, J Merrill3

  • 1Monash University.

Expert Opinion on Investigational Drugs
|May 29, 2024
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
08:36

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on: April 7, 2023

1.1K
Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

123

Related Experiment Videos

Last Updated: Jun 25, 2025

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

2.9K
Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
08:36

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on: April 7, 2023

1.1K
Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

123

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

8.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.8K

Articles linked to this work by shared authors, journal, and citation graph.

Efficacy and safety of litifilimab in cutaneous lupus erythematosus: 24-week results of the randomized phase 2 study, AMETHYST.

Journal of the American Academy of Dermatology·2026

Treat-to-target: LLDAS, DORIS remission, and flare prevention strategies.

Rheumatology (Oxford, England)·2026

Longitudinal Comparison of Treat-to-Target States and Clinical Outcomes in Patients With Late-Onset Versus Early-Onset Systemic Lupus Erythematosus.

The Journal of rheumatology·2026

Pharmacodynamic analysis of TYK2 inhibition by deucravacitinib: results from the phase 2 PAISLEY SLE trial in patients with active systemic lupus erythematosus.

Annals of the rheumatic diseases·2026

High disease activity persists in adults with childhood-onset lupus.

Lupus science & medicine·2026

Anifrolumab Plus Standard of Care Reduces Long-Term Cardiovascular Damage in Adults With Systemic Lupus Erythematosus: Findings From a Real-World External Control Study.

ACR open rheumatology·2026

Zovegalisib for PIK3CA-driven vascular and lymphatic malformations: a drug evaluation.

Expert opinion on investigational drugs·2026

Targeting the proteasome in Leishmania donovani: developments from preclinical to Phase I and ii trials.

Expert opinion on investigational drugs·2026

Evaluating early systemic therapies in the neoadjuvant setting for the treatment of urological cancers.

Expert opinion on investigational drugs·2026

Emerging therapeutic strategies and clinical development of investigational agents for conventional chondrosarcoma.

Expert opinion on investigational drugs·2026

Safety, pharmacokinetics, pharmacodynamics and target-mediated drug disposition modeling of TST002, a sclerostin antibody, in men and postmenopausal women with low bone mineral density.

Expert opinion on investigational drugs·2026

Innovative therapies under clinical development for ALS treatment. Part 2: biologics and natural products.

Expert opinion on investigational drugs·2026

Integrated UHPLC-MS/MS and DrugCIPHER-Based Network Pharmacology to Identify Signature Components and Evaluate Pharmacokinetics of Biyuan Tongqiao Granules in Rats.

Biomedical chromatography : BMC·2026

Validation and predictive performance of a physiologically based single dose pharmacokinetic model of mirtazapine for elderly and pediatric populations.

Canadian journal of physiology and pharmacology·2026

Plasma proteomic analysis identified potential therapeutic targets for pulmonary arterial hypertension.

iScience·2026

Economic evaluation of tirzepatide, semaglutide, and liraglutide in the treatment of obese and overweight patients without diabetes: a short-term cost-effectiveness analysis in Iran.

Journal of diabetes and metabolic disorders·2026

Prediction of bacteria-specific drug metabolism using a cross-attention-based model.

Briefings in bioinformatics·2026

Effects of prucalopride on anxiety and depressive symptoms among constipated patients: A meta-analysis of randomized controlled trials.

Psychiatry and clinical neurosciences·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us